First cardiac manifestation of hypotonia-cystinuria syndrome

  • Mustafa Kılıç
  • Ahmet Cevdet Ceylan
  • Utku Arman Örün
  • Esra Kılıç
Short Communication
  • 14 Downloads

Abstract

Hypotonia-cystinuria syndrome is a very rare autosomal recessive contiguous gene deletion syndrome of PREPL and SLC3A1 at 2p21 with neuromuscular and neuroendocrinologic presentation. We report a two-year-six-month-old affected female infant and her five-month-old affected brother with a novel homozygous deletion in SLC3A1 and PREPL gene. Both of siblings had mild facial dysmorphism, hypotonia, feeding problems, failure to thrive, developmental delay. She also had dilated cardiomyopathy which differ from other reported patients. Therefore cardiomyopathy may also be considered one of the features of hypotonia-cystinuria syndrome. With this case report, we present cardiac manifestation of hypotonia-cystinuria syndrome for the first time. Because of two siblings had hyperechogenic bowel in prenatal sonography, it might be a prenatal marker for HCS.

Keywords

SLC3A1 PREPL Hypotonia-cystinuria syndrome Developmental delay Growth failure Non-compaction 

Notes

Acknowledgements

We thank the family for cooperation.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Bartholdi D, Asadollahi R, Oneda B, Schmitt-Mechelke T, Tonella P, Baumer A, Rauch A (2013) Further delineation of genotype-phenotype correlation in homozygous 2p21 deletion syndromes: first description of patients without cystinuria. Am J Med Genet A 161:1853–1859CrossRefGoogle Scholar
  2. Boonen K, Régal L, Jaeken J, Creemers JW (2011) PREPL, a prolyl endopeptidase-like enzyme by name only?--lessons from patients. CNS Neurol Disord Drug Targets 10:355–360CrossRefPubMedGoogle Scholar
  3. Chabrol B, Martens K, Meulemans S, Cano A, Jaeken J, Matthijs G, Creemers JW (2008) Deletion of C2orf34, PREPL and SLC3A1 causes atypical hypotonia-cystinuria syndrome. J Med Genet 45:314–318CrossRefPubMedGoogle Scholar
  4. Clara R, Lowenthal A (1966) Familial aminoaciduria with muscular hypotonia and dwarfism. Bull Acad R Med Belg 6:577–611PubMedGoogle Scholar
  5. Eggermann T, Spengler S, Venghaus A, Denecke B, Zerres K, Baudis M, Ensenauer R (2012) 2p21 deletions in hypotonia-cystinuria syndrome. Eur J Med Genet 55:561–563.  https://doi.org/10.1016/j.ejmg.2012.06.008 CrossRefPubMedGoogle Scholar
  6. Jaeken J, Martens K, Francois I et al (2006) Deletion of PREPL, a gene encoding a putative serine oligopeptidase, in patients with hypotonia-cystinuria syndrome. Am J Hum Genet 78:38–51CrossRefPubMedGoogle Scholar
  7. Jaeken J, Creemers J, Régal L (2012) Evaluation of the pediatric patient with hypotonia: don't forget the hypotonia-cystinuria syndrome! Dev Med Child Neurol 54:288CrossRefPubMedGoogle Scholar
  8. Legati A, Reyes A, Nasca A et al (2016) New genes and pathomechanisms in mitochondrial disorders unraveled by NGS technologies. Biochim Biophys Acta 1857(8):1326–1335.  https://doi.org/10.1016/j.bbabio.2016.02.022 CrossRefPubMedGoogle Scholar
  9. Martens K, Heulens I, Meulemans S et al (2007) Global distribution of the most prevalent deletions causing hypotonia-cystinuria syndrome. Eur J Hum Genet 15:1029–1033CrossRefPubMedGoogle Scholar
  10. Martens K, Jaeken J, Matthijs G, Creemers JW (2008) Multi-system disorder syndromes associated with cystinuria type I. Curr Mol Med 8:544–550CrossRefPubMedGoogle Scholar
  11. Parvari R, Brodyansky I, Elpeleg O, Moses S, Landau D, Hershkovitz E (2001) A recessive contiguous gene deletion of chromosome 2p16 associated with cystinuria and a mitochondrial disease. Am J Hum Genet 69:869–875CrossRefPubMedPubMedCentralGoogle Scholar
  12. Régal L, Aydin HI, Dieltjens AM et al (2012) Two novel deletions in hypotonia-cystinuria syndrome. Mol Genet Metab 107:614–616CrossRefPubMedGoogle Scholar
  13. Régal L, Shen XM, Selcen D, Verhille C, Meulemans S, Creemers JW, Engel AG (2014) PREPL deficiency with or without cystinuria causes a novel myasthenic syndrome. Neurology 82:1254–1260CrossRefPubMedPubMedCentralGoogle Scholar
  14. Régal L, Mårtensson E, Maystadt I et al (2017) PREPL deficiency: delineation of the phenotype and development of a functional blood assay. Genet Med 20:109–118.  https://doi.org/10.1038/gim.2017.74 CrossRefPubMedGoogle Scholar
  15. Wortmann SB, Koolen DA, Smeitink JA, van den Heuvel L, Rodenburg RJ (2015) Whole exome sequencing of suspected mitochondrial patients in clinical practice. J Inherit Metab Dis 38:437–443.  https://doi.org/10.1007/s10545-015-9823-y CrossRefPubMedPubMedCentralGoogle Scholar
  16. Zaffanello M, Beghini R, Zamboni G, Fanos V (2003) A sporadic case of cystinuria, respiratory chain and growth hormone deficiencies. Pediatr Nephrol 18:846–847CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Mustafa Kılıç
    • 1
  • Ahmet Cevdet Ceylan
    • 2
  • Utku Arman Örün
    • 3
  • Esra Kılıç
    • 4
  1. 1.Sami Ulus Children Hospital, Metabolism UnitAnkaraTurkey
  2. 2.Atatürk Training and Research Hospital, Department of GeneticsYıldırım Beyazıt UniversityAnkaraTurkey
  3. 3.Pediatric Cardiology UnitSami Ulus Children HospitalAnkaraTurkey
  4. 4.Pediatric Hematology-Oncology Training and Research HospitalAnkaraTurkey

Personalised recommendations